Subscribe
Drug pricing on the agenda for massive infrastructure bill

Health Affairs This Week

Drug pricing on the agenda for massive infrastructure bill

Listen to Chris Fleming and Washington University's Rachel Sachs break down H.R. 3, which contains a series of far-reaching drug pricing reforms that could be included as part of a…
April 2, 2021
ADVERTISEMENT
Wise-Formerly Transferwise

Drug pricing on the agenda for massive infrastructure bill

It’s Infrastructure Week and H.R. 3, a far-reaching piece of legislation which contains a series of drug-pricing reforms, is back.

At the end of 2019, the House of Representatives passed H.R. 3 but partisan disagreements prevented the bill from becoming law. Now, elements of H.R. 3 are back on the table as the Biden administration prepares its $2 trillion infrastructure and jobs package.

Washington University’s Rachel Sachs joins Health Affairs’ Chris Fleming to break down H.R. 3’s three main parts and highlight what they mean for the federal budget, pharmaceutical companies, and consumers.

Related Links:

Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

ADVERTISEMENT
WP Engine Wordpress Hosting

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.